Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C, Chronic

Explore clinical trials studying Hepatitis C, Chronic. Study availability and eligibility vary by location and protocol.

314 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C, Chronic trial results

Completed

A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1

NCT01448200

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Investigational site Costa Mesa, California, United States
  • Investigational site Sacramento, California, United States
  • Investigational site San Francisco, California, United States
  • Investigational Site San Antonio, Texas, United States
View Trial Details
Completed

A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients

NCT00088140

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Scripps Clinic La Jolla, California, United States
  • California Pacific Medical Center San Francisco, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 15 locations
View Trial Details
Completed

SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C

NCT00110799

Conditions
Blood Platelet Disorders, Blood-Borne Infections, Chronic Disease, +20 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site St Louis, Missouri, United States
View all 30 locations
View Trial Details
Completed

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.

NCT00545233

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Birmingham, Alabama, United States
  • Tucson, Arizona, United States
  • Anaheim, California, United States
  • Fresno, California, United States
View all 66 locations
View Trial Details
Completed

A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects With Chronic Hepatitis C Virus Infection

NCT01316237

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Advanced Clinical Research Institute Anaheim, California, United States
  • Axis Clinical Trials Los Angeles, California, United States
  • Avail Clinical Research, LLC DeLand, Florida, United States
  • University of Florida - Gainesville Gainesville, Florida, United States
View all 13 locations
View Trial Details
Completed

Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV

NCT00863239

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • eStudy site Chula Vista, California, United States
  • eStudy Site Oceanside, California, United States
  • Medical Associates Research Group San Diego, California, United States
  • University of Louisville Health Care Outpatient Center Louisville, Kentucky, United States
View all 24 locations
View Trial Details

Related conditions